Abstract
Objective To test the hypothesis that depression is associated with differential neurodevelopment of reward circuitry in adolescence.
Methods Adolescent girls (N=183, 58 with MDD in early or late adolescence) underwent MRI scans from ages 16-20 (1-4 scans/participant, 477 scans total) and completed a card-guessing fMRI task with monetary rewards. Mixed-effect models tested the effect of age and the moderating effect of MDD on whole-brain regional activation during reward anticipation.
Results Eighty of 414 regions showed age effects (pFDR<0.05), consisting primarily of increasing activation with increasing age. Most significant regions were in dorsal attention, salience, and somatomotor networks, and also included the bilateral putamen, pallidum, and right nucleus accumbens. MDD moderated age effects in 40 regions (pFDR<0.05), including the right putamen, medial orbitofrontal cortex, and amygdala, and regions in control and dorsal attention networks. MDD x linear and quadratic age effects were negative, suggesting that MDD was associated with accelerated neurodevelopment.
Conclusions Theories of reward processing’s contribution to adolescent risk for depression focus primarily on core reward regions, yet a host of regions beyond these continue to develop during late adolescence. Findings demonstrate differing regional patterns of age-related changes in relation to MDD in girls, suggesting that depression involves disruption of a wide range of regions during reward anticipation processing across adolescence. Childhood and adolescent MDD is associated with accelerated neurodevelopment of attention and cognitive control regions during reward anticipation processing, which may have consequences both for cognitive function and the emergence of reward-system-specific disruptions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by grants from the National Institutes of Mental Health, including MH093605 (Guyer, Keenan, Forbes), and DB was supported by T32 MH018951 (Goldstein).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of the University of Pittsburgh gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
Summary statistics generated by these analyses are provided in the Supplemental Data file. Formal data sharing proposal and agreement forms for the Pittsburgh Girls Study - Emotions Substudy can be requested from senior authors Dr. Keenan (kekeenan{at}uchicago.edu) or Dr. Hipwell (hipwae{at}upmc.edu).
